SK Discovery (006120) Q3 2024 earnings summary

Executive summary

• The group operates as a pure holding company, with major subsidiaries in green chemicals, life sciences, gas, plasma, real estate, renewable energy, and bio businesses.

• Key subsidiaries include SK Chemicals, SK Gas, SK Plasma, SK D&D, SK Biopharmaceuticals, and others, each with distinct business lines.

• The group’s revenue is highly diversified, with significant contributions from LPG trading, green chemicals, pharmaceuticals, and real estate.

Financial highlights

• Consolidated revenue for the first nine months of 2024 was ₩6,467.6 billion, down from ₩8,939.2 billion in the same period last year.

• Operating profit was ₩100.1 billion, a sharp decline from ₩256.7 billion year-over-year.

• Net income attributable to controlling interests was ₩39.5 billion, compared to ₩191.0 billion in the prior year.

• Basic EPS for common shares was ₩2,048, down from ₩9,699 year-over-year.

• Total assets at quarter-end were ₩13,420.0 billion, with total equity of ₩6,103.2 billion.

Outlook and guidance

• The group continues to invest in green chemicals, recycling, and bio-based materials, with ongoing expansion in renewable energy and bio-pharmaceuticals.

• Ongoing R&D and capital investments are expected to support long-term growth, despite short-term margin pressures.